The top executives for companies in the hospice space have expressed serious concerns about the forthcoming inclusion of hospice in Medicare’s value-based insurance design model, often called the Medicare Advantage hospice carve-in. Through Medicare Advantage, CMS contracts with private insurance companies to provide coverage for Medicare beneficiaries. CMS earlier this year announced that it would test coverage of hospice care through Medicare Advantage plans beginning in 2021.The agency began accepting applications for participation in the program in Dec. 2019. The carve-in, according to CMS, is intended to increase access to hospice services and facilitate better coordination between patients’ hospice providers and their other clinicians. Reactions to the carve-in demo have been mixed.
Read the full article: Hospice CEOs Voice Misgivings on Medicare Advantage //